Tumor budding in upper urinary tract urothelial carcinoma: a putative prognostic factor for extraurothelial recurrence and overall survival View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2021-01-06

AUTHORS

Kazuki Kawamura, Kosuke Miyai, Junichi Asakuma, Kimiya Sato, Susumu Matsukuma, Hitoshi Tsuda, Keiichi Ito

ABSTRACT

Tumor budding, defined as a single cancer cell or clusters of fewer than five cancer cells observed at the tumor invasion front, has been reported to be associated with poor prognosis in various types of cancers. However, limited information regarding the pathological and prognostic significance of tumor budding in upper urinary tract urothelial carcinoma (UUTUC) is available. We investigated 135 consecutive patients with newly diagnosed invasive UUTUCs (73 with renal pelvic cancers and 62 with ureteral cancers) treated with nephroureterectomy or partial ureterectomy between 1999 and 2018 in our hospital. Under a × 200 magnification, tumors with 10 or more budding foci were defined as “high tumor budding”. The median follow-up period was 53.6 months. Among the 135 patients, 41 (30%; 16 with renal pelvic cancers and 25 with ureteral cancers) showed high tumor budding. High tumor budding was related to adjuvant chemotherapy status, higher pathological T stage, lymphovascular invasion, lymph node metastasis, tumor location, concomitant variant histology, and non-papillary gross finding. The multivariate Cox analysis revealed that LVI and high tumor budding were independent predictors for extraurothelial recurrence (P = 0.039 and 0.014, hazard ratio = 2.50 and 2.88, respectively), and high tumor budding was an independent predictor for overall survival (P = 0.024, hazard ratio = 2.33). Tumor budding can be easily introduced in clinical practice with no need for immunohistochemical analysis, may be an important clinicopathological factor of UUTUC, and is suggested to be useful as a novel predictive prognostic factor of patients with invasive UUTUC. More... »

PAGES

45-55

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00428-020-02989-0

DOI

http://dx.doi.org/10.1007/s00428-020-02989-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1134365501

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/33404852


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Movement", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemotherapy, Adjuvant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphatic Metastasis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Invasiveness", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nephrectomy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Progression-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Assessment", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ureteral Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Urothelium", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Urology, National Defense Medical College, Tokorozawa, Saitama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.416614.0", 
          "name": [
            "Department of Urology, National Defense Medical College, Tokorozawa, Saitama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kawamura", 
        "givenName": "Kazuki", 
        "id": "sg:person.014234730677.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014234730677.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Laboratory Medicine, National Defense Medical College, Tokorozawa, Saitama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.416614.0", 
          "name": [
            "Department of Basic Pathology, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan", 
            "Department of Laboratory Medicine, National Defense Medical College, Tokorozawa, Saitama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miyai", 
        "givenName": "Kosuke", 
        "id": "sg:person.01307144321.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307144321.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Urology, National Defense Medical College, Tokorozawa, Saitama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.416614.0", 
          "name": [
            "Department of Urology, National Defense Medical College, Tokorozawa, Saitama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Asakuma", 
        "givenName": "Junichi", 
        "id": "sg:person.01053317013.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01053317013.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Basic Pathology, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.416614.0", 
          "name": [
            "Department of Basic Pathology, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sato", 
        "givenName": "Kimiya", 
        "id": "sg:person.012221777264.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012221777264.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Laboratory Medicine, National Defense Medical College, Tokorozawa, Saitama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.416614.0", 
          "name": [
            "Department of Laboratory Medicine, National Defense Medical College, Tokorozawa, Saitama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matsukuma", 
        "givenName": "Susumu", 
        "id": "sg:person.01042572065.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042572065.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Basic Pathology, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.416614.0", 
          "name": [
            "Department of Basic Pathology, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tsuda", 
        "givenName": "Hitoshi", 
        "id": "sg:person.07547136242.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07547136242.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Urology, National Defense Medical College, Tokorozawa, Saitama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.416614.0", 
          "name": [
            "Department of Urology, National Defense Medical College, Tokorozawa, Saitama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ito", 
        "givenName": "Keiichi", 
        "id": "sg:person.0742101353.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0742101353.31"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/bjc.2013.797", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010521175", 
          "https://doi.org/10.1038/bjc.2013.797"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-012-2426-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003634868", 
          "https://doi.org/10.1245/s10434-012-2426-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00428-020-02745-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1124124072", 
          "https://doi.org/10.1007/s00428-020-02745-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/modpathol.2010.88", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002108517", 
          "https://doi.org/10.1038/modpathol.2010.88"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00464-013-3321-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032498264", 
          "https://doi.org/10.1007/s00464-013-3321-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-015-3333-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028418850", 
          "https://doi.org/10.1007/s10549-015-3333-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00384-006-0249-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045387511", 
          "https://doi.org/10.1007/s00384-006-0249-8"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-01-06", 
    "datePublishedReg": "2021-01-06", 
    "description": "Tumor budding, defined as a single cancer cell or clusters of fewer than five cancer cells observed at the tumor invasion front, has been reported to be associated with poor prognosis in various types of cancers. However, limited information regarding the pathological and prognostic significance of tumor budding in upper urinary tract urothelial carcinoma (UUTUC) is available. We investigated 135 consecutive patients with newly diagnosed invasive UUTUCs (73 with renal pelvic cancers and 62 with ureteral cancers) treated with nephroureterectomy or partial ureterectomy between 1999 and 2018 in our hospital. Under a \u00d7\u2009200 magnification, tumors with 10 or more budding foci were defined as \u201chigh tumor budding\u201d. The median follow-up period was 53.6\u00a0months. Among the 135 patients, 41 (30%; 16 with renal pelvic cancers and 25 with ureteral cancers) showed high tumor budding. High tumor budding was related to adjuvant chemotherapy status, higher pathological T stage, lymphovascular invasion, lymph node metastasis, tumor location, concomitant variant histology, and non-papillary gross finding. The multivariate Cox analysis revealed that LVI and high tumor budding were independent predictors for extraurothelial recurrence (P\u2009=\u20090.039 and 0.014, hazard ratio\u2009=\u20092.50 and 2.88, respectively), and high tumor budding was an independent predictor for overall survival (P\u2009=\u20090.024, hazard ratio\u2009=\u20092.33). Tumor budding can be easily introduced in clinical practice with no need for immunohistochemical analysis, may be an important clinicopathological factor of UUTUC, and is suggested to be useful as a novel predictive prognostic factor of patients with invasive UUTUC.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00428-020-02989-0", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1106235", 
        "issn": [
          "0945-6317", 
          "1432-2307"
        ], 
        "name": "Virchows Archiv", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "479"
      }
    ], 
    "keywords": [
      "upper urinary tract urothelial carcinoma", 
      "high tumor budding", 
      "urinary tract urothelial carcinoma", 
      "tumor budding", 
      "extraurothelial recurrence", 
      "overall survival", 
      "independent predictors", 
      "prognostic factors", 
      "urothelial carcinoma", 
      "higher pathological T stage", 
      "adjuvant chemotherapy status", 
      "concomitant variant histology", 
      "important clinicopathological factors", 
      "predictive prognostic factors", 
      "cancer cells", 
      "pathological T stage", 
      "lymph node metastasis", 
      "multivariate Cox analysis", 
      "putative prognostic factors", 
      "tumor invasion front", 
      "types of cancer", 
      "median follow", 
      "chemotherapy status", 
      "variant histology", 
      "partial ureterectomy", 
      "lymphovascular invasion", 
      "consecutive patients", 
      "node metastasis", 
      "Cox analysis", 
      "clinicopathological factors", 
      "T stage", 
      "poor prognosis", 
      "prognostic significance", 
      "tumor location", 
      "gross findings", 
      "immunohistochemical analysis", 
      "clinical practice", 
      "patients", 
      "tumors", 
      "carcinoma", 
      "recurrence", 
      "single cancer cells", 
      "survival", 
      "predictors", 
      "limited information", 
      "invasion front", 
      "nephroureterectomy", 
      "ureterectomy", 
      "cells", 
      "prognosis", 
      "metastasis", 
      "hospital", 
      "follow", 
      "histology", 
      "cancer", 
      "factors", 
      "months", 
      "invasion", 
      "budding", 
      "LVI", 
      "status", 
      "findings", 
      "period", 
      "significance", 
      "analysis", 
      "magnification", 
      "need", 
      "stage", 
      "practice", 
      "types", 
      "focus", 
      "information", 
      "location", 
      "clusters", 
      "front"
    ], 
    "name": "Tumor budding in upper urinary tract urothelial carcinoma: a putative prognostic factor for extraurothelial recurrence and overall survival", 
    "pagination": "45-55", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1134365501"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00428-020-02989-0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "33404852"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00428-020-02989-0", 
      "https://app.dimensions.ai/details/publication/pub.1134365501"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T21:07", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_893.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00428-020-02989-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00428-020-02989-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00428-020-02989-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00428-020-02989-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00428-020-02989-0'


 

This table displays all metadata directly associated to this object as RDF triples.

298 TRIPLES      21 PREDICATES      129 URIs      114 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00428-020-02989-0 schema:about N00d6d3f2500a486aaf441d829b3af4f5
2 N08e33182e8a24768aa862ccda4efb32e
3 N09bfa9833d0c421b8e5b3ae58da5bf38
4 N1bb1866805824e63bef6a115990e4d66
5 N4a71615d220f4c2f97d7a22241845f23
6 N789fea8144d24ea1ab60522109a82058
7 N7d630785a9c84c9e839a3d74a462802f
8 N7f73dd4e6bc141acb2f517a42e4f0fd8
9 N81d675649aeb40b9a1c17228199e2879
10 N900ca9e55c3c4f909dc68d24f78ead51
11 N96735a2784a04494b351e48306ca02f6
12 Na9f908a7df5c4b69955355a4eab5b23d
13 Naad1998fbaab4aab88845dc9f14bd739
14 Nc670d618f317445e93e89f5cc34e6e88
15 Nd2dcb6248a8b4fabb8212694e9491767
16 Ndc2166abba9745f7ab17003621526383
17 Ne39b46c669be477ebf2676b31631cb6d
18 Nec0ab591b10e472ca42658de21622a0a
19 Ned565fc3b744409f810b1eb04017833a
20 Nf06d7713aeb24f95ab25332091c4b707
21 Nf68b51907e1549bca41b8456663fcda6
22 Nf6bc3f5d1c6140bdb99f39a46880a213
23 anzsrc-for:11
24 anzsrc-for:1112
25 schema:author N546ee8813cc241a08a9bef49fa6d1c26
26 schema:citation sg:pub.10.1007/s00384-006-0249-8
27 sg:pub.10.1007/s00428-020-02745-4
28 sg:pub.10.1007/s00464-013-3321-9
29 sg:pub.10.1007/s10549-015-3333-3
30 sg:pub.10.1038/bjc.2013.797
31 sg:pub.10.1038/modpathol.2010.88
32 sg:pub.10.1245/s10434-012-2426-z
33 schema:datePublished 2021-01-06
34 schema:datePublishedReg 2021-01-06
35 schema:description Tumor budding, defined as a single cancer cell or clusters of fewer than five cancer cells observed at the tumor invasion front, has been reported to be associated with poor prognosis in various types of cancers. However, limited information regarding the pathological and prognostic significance of tumor budding in upper urinary tract urothelial carcinoma (UUTUC) is available. We investigated 135 consecutive patients with newly diagnosed invasive UUTUCs (73 with renal pelvic cancers and 62 with ureteral cancers) treated with nephroureterectomy or partial ureterectomy between 1999 and 2018 in our hospital. Under a × 200 magnification, tumors with 10 or more budding foci were defined as “high tumor budding”. The median follow-up period was 53.6 months. Among the 135 patients, 41 (30%; 16 with renal pelvic cancers and 25 with ureteral cancers) showed high tumor budding. High tumor budding was related to adjuvant chemotherapy status, higher pathological T stage, lymphovascular invasion, lymph node metastasis, tumor location, concomitant variant histology, and non-papillary gross finding. The multivariate Cox analysis revealed that LVI and high tumor budding were independent predictors for extraurothelial recurrence (P = 0.039 and 0.014, hazard ratio = 2.50 and 2.88, respectively), and high tumor budding was an independent predictor for overall survival (P = 0.024, hazard ratio = 2.33). Tumor budding can be easily introduced in clinical practice with no need for immunohistochemical analysis, may be an important clinicopathological factor of UUTUC, and is suggested to be useful as a novel predictive prognostic factor of patients with invasive UUTUC.
36 schema:genre article
37 schema:isAccessibleForFree false
38 schema:isPartOf N18e8ca31e92c4a639de58e747d79ef27
39 Ndf158e8b64294513b38d1da472d51043
40 sg:journal.1106235
41 schema:keywords Cox analysis
42 LVI
43 T stage
44 adjuvant chemotherapy status
45 analysis
46 budding
47 cancer
48 cancer cells
49 carcinoma
50 cells
51 chemotherapy status
52 clinical practice
53 clinicopathological factors
54 clusters
55 concomitant variant histology
56 consecutive patients
57 extraurothelial recurrence
58 factors
59 findings
60 focus
61 follow
62 front
63 gross findings
64 high tumor budding
65 higher pathological T stage
66 histology
67 hospital
68 immunohistochemical analysis
69 important clinicopathological factors
70 independent predictors
71 information
72 invasion
73 invasion front
74 limited information
75 location
76 lymph node metastasis
77 lymphovascular invasion
78 magnification
79 median follow
80 metastasis
81 months
82 multivariate Cox analysis
83 need
84 nephroureterectomy
85 node metastasis
86 overall survival
87 partial ureterectomy
88 pathological T stage
89 patients
90 period
91 poor prognosis
92 practice
93 predictive prognostic factors
94 predictors
95 prognosis
96 prognostic factors
97 prognostic significance
98 putative prognostic factors
99 recurrence
100 significance
101 single cancer cells
102 stage
103 status
104 survival
105 tumor budding
106 tumor invasion front
107 tumor location
108 tumors
109 types
110 types of cancer
111 upper urinary tract urothelial carcinoma
112 ureterectomy
113 urinary tract urothelial carcinoma
114 urothelial carcinoma
115 variant histology
116 schema:name Tumor budding in upper urinary tract urothelial carcinoma: a putative prognostic factor for extraurothelial recurrence and overall survival
117 schema:pagination 45-55
118 schema:productId N08baf8a44b9f4640b318291071702819
119 N85902a2a5e3e4176ae52629874b92192
120 N99c9c6c94ba3421b8bd46245c6631e89
121 schema:sameAs https://app.dimensions.ai/details/publication/pub.1134365501
122 https://doi.org/10.1007/s00428-020-02989-0
123 schema:sdDatePublished 2022-11-24T21:07
124 schema:sdLicense https://scigraph.springernature.com/explorer/license/
125 schema:sdPublisher N6d9d118652094c0390aa44527308bab1
126 schema:url https://doi.org/10.1007/s00428-020-02989-0
127 sgo:license sg:explorer/license/
128 sgo:sdDataset articles
129 rdf:type schema:ScholarlyArticle
130 N00d6d3f2500a486aaf441d829b3af4f5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Risk Assessment
132 rdf:type schema:DefinedTerm
133 N08baf8a44b9f4640b318291071702819 schema:name doi
134 schema:value 10.1007/s00428-020-02989-0
135 rdf:type schema:PropertyValue
136 N08e33182e8a24768aa862ccda4efb32e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Lymphatic Metastasis
138 rdf:type schema:DefinedTerm
139 N09bfa9833d0c421b8e5b3ae58da5bf38 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Chemotherapy, Adjuvant
141 rdf:type schema:DefinedTerm
142 N18e8ca31e92c4a639de58e747d79ef27 schema:volumeNumber 479
143 rdf:type schema:PublicationVolume
144 N1bb1866805824e63bef6a115990e4d66 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Cell Movement
146 rdf:type schema:DefinedTerm
147 N265a83b4a833480581e2bcb2d178af14 rdf:first sg:person.01307144321.06
148 rdf:rest N92c81d2b0bcb461e971b09744f798f11
149 N4a71615d220f4c2f97d7a22241845f23 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Risk Factors
151 rdf:type schema:DefinedTerm
152 N546ee8813cc241a08a9bef49fa6d1c26 rdf:first sg:person.014234730677.70
153 rdf:rest N265a83b4a833480581e2bcb2d178af14
154 N6d9d118652094c0390aa44527308bab1 schema:name Springer Nature - SN SciGraph project
155 rdf:type schema:Organization
156 N789fea8144d24ea1ab60522109a82058 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Urothelium
158 rdf:type schema:DefinedTerm
159 N7d630785a9c84c9e839a3d74a462802f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Progression-Free Survival
161 rdf:type schema:DefinedTerm
162 N7f73dd4e6bc141acb2f517a42e4f0fd8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Nephrectomy
164 rdf:type schema:DefinedTerm
165 N81d675649aeb40b9a1c17228199e2879 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Time Factors
167 rdf:type schema:DefinedTerm
168 N85902a2a5e3e4176ae52629874b92192 schema:name dimensions_id
169 schema:value pub.1134365501
170 rdf:type schema:PropertyValue
171 N900ca9e55c3c4f909dc68d24f78ead51 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Humans
173 rdf:type schema:DefinedTerm
174 N92c81d2b0bcb461e971b09744f798f11 rdf:first sg:person.01053317013.81
175 rdf:rest Nc6102eaf4b6646da8805aa016b965467
176 N96735a2784a04494b351e48306ca02f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Aged, 80 and over
178 rdf:type schema:DefinedTerm
179 N99c9c6c94ba3421b8bd46245c6631e89 schema:name pubmed_id
180 schema:value 33404852
181 rdf:type schema:PropertyValue
182 Na1a0b89bd7d64285ad9caf9468ee8b8b rdf:first sg:person.01042572065.02
183 rdf:rest Nf7e77c9b33dd43f38aceade367fe960b
184 Na9f908a7df5c4b69955355a4eab5b23d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Female
186 rdf:type schema:DefinedTerm
187 Naad1998fbaab4aab88845dc9f14bd739 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Aged
189 rdf:type schema:DefinedTerm
190 Nc6102eaf4b6646da8805aa016b965467 rdf:first sg:person.012221777264.54
191 rdf:rest Na1a0b89bd7d64285ad9caf9468ee8b8b
192 Nc670d618f317445e93e89f5cc34e6e88 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Kidney Neoplasms
194 rdf:type schema:DefinedTerm
195 Nd2dcb6248a8b4fabb8212694e9491767 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Male
197 rdf:type schema:DefinedTerm
198 Ndc2166abba9745f7ab17003621526383 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
199 schema:name Carcinoma
200 rdf:type schema:DefinedTerm
201 Ndf158e8b64294513b38d1da472d51043 schema:issueNumber 1
202 rdf:type schema:PublicationIssue
203 Ne39b46c669be477ebf2676b31631cb6d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
204 schema:name Middle Aged
205 rdf:type schema:DefinedTerm
206 Nec0ab591b10e472ca42658de21622a0a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
207 schema:name Adult
208 rdf:type schema:DefinedTerm
209 Ned1e62173d8c45f4a938fa8dba2100aa rdf:first sg:person.0742101353.31
210 rdf:rest rdf:nil
211 Ned565fc3b744409f810b1eb04017833a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
212 schema:name Neoplasm Invasiveness
213 rdf:type schema:DefinedTerm
214 Nf06d7713aeb24f95ab25332091c4b707 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
215 schema:name Neoplasm Staging
216 rdf:type schema:DefinedTerm
217 Nf68b51907e1549bca41b8456663fcda6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
218 schema:name Neoplasm Recurrence, Local
219 rdf:type schema:DefinedTerm
220 Nf6bc3f5d1c6140bdb99f39a46880a213 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
221 schema:name Ureteral Neoplasms
222 rdf:type schema:DefinedTerm
223 Nf7e77c9b33dd43f38aceade367fe960b rdf:first sg:person.07547136242.70
224 rdf:rest Ned1e62173d8c45f4a938fa8dba2100aa
225 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
226 schema:name Medical and Health Sciences
227 rdf:type schema:DefinedTerm
228 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
229 schema:name Oncology and Carcinogenesis
230 rdf:type schema:DefinedTerm
231 sg:journal.1106235 schema:issn 0945-6317
232 1432-2307
233 schema:name Virchows Archiv
234 schema:publisher Springer Nature
235 rdf:type schema:Periodical
236 sg:person.01042572065.02 schema:affiliation grid-institutes:grid.416614.0
237 schema:familyName Matsukuma
238 schema:givenName Susumu
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042572065.02
240 rdf:type schema:Person
241 sg:person.01053317013.81 schema:affiliation grid-institutes:grid.416614.0
242 schema:familyName Asakuma
243 schema:givenName Junichi
244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01053317013.81
245 rdf:type schema:Person
246 sg:person.012221777264.54 schema:affiliation grid-institutes:grid.416614.0
247 schema:familyName Sato
248 schema:givenName Kimiya
249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012221777264.54
250 rdf:type schema:Person
251 sg:person.01307144321.06 schema:affiliation grid-institutes:grid.416614.0
252 schema:familyName Miyai
253 schema:givenName Kosuke
254 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307144321.06
255 rdf:type schema:Person
256 sg:person.014234730677.70 schema:affiliation grid-institutes:grid.416614.0
257 schema:familyName Kawamura
258 schema:givenName Kazuki
259 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014234730677.70
260 rdf:type schema:Person
261 sg:person.0742101353.31 schema:affiliation grid-institutes:grid.416614.0
262 schema:familyName Ito
263 schema:givenName Keiichi
264 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0742101353.31
265 rdf:type schema:Person
266 sg:person.07547136242.70 schema:affiliation grid-institutes:grid.416614.0
267 schema:familyName Tsuda
268 schema:givenName Hitoshi
269 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07547136242.70
270 rdf:type schema:Person
271 sg:pub.10.1007/s00384-006-0249-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045387511
272 https://doi.org/10.1007/s00384-006-0249-8
273 rdf:type schema:CreativeWork
274 sg:pub.10.1007/s00428-020-02745-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1124124072
275 https://doi.org/10.1007/s00428-020-02745-4
276 rdf:type schema:CreativeWork
277 sg:pub.10.1007/s00464-013-3321-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032498264
278 https://doi.org/10.1007/s00464-013-3321-9
279 rdf:type schema:CreativeWork
280 sg:pub.10.1007/s10549-015-3333-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028418850
281 https://doi.org/10.1007/s10549-015-3333-3
282 rdf:type schema:CreativeWork
283 sg:pub.10.1038/bjc.2013.797 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010521175
284 https://doi.org/10.1038/bjc.2013.797
285 rdf:type schema:CreativeWork
286 sg:pub.10.1038/modpathol.2010.88 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002108517
287 https://doi.org/10.1038/modpathol.2010.88
288 rdf:type schema:CreativeWork
289 sg:pub.10.1245/s10434-012-2426-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1003634868
290 https://doi.org/10.1245/s10434-012-2426-z
291 rdf:type schema:CreativeWork
292 grid-institutes:grid.416614.0 schema:alternateName Department of Basic Pathology, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan
293 Department of Laboratory Medicine, National Defense Medical College, Tokorozawa, Saitama, Japan
294 Department of Urology, National Defense Medical College, Tokorozawa, Saitama, Japan
295 schema:name Department of Basic Pathology, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan
296 Department of Laboratory Medicine, National Defense Medical College, Tokorozawa, Saitama, Japan
297 Department of Urology, National Defense Medical College, Tokorozawa, Saitama, Japan
298 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...